Podcast Episodes

Back to Search
MAMA: 55% Growth Meets 96x Valuation Reality
MAMA: 55% Growth Meets 96x Valuation Reality

MAMA delivers 55% growth at a 95x valuation — food stock analysis: buy or sell?

👉 Want this level of research on ANY COMPANY IN THE WORLD... for FREE…

3 weeks, 5 days ago

Short Long
View Episode
LENZ: Inside the $220M Biotech Burning Below Cash
LENZ: Inside the $220M Biotech Burning Below Cash

LENZ stock analysis: trading at -$40M EV signals a massive market disconnect — deep dive

👉 Want this level of research on ANY COMPANY IN THE WORLD...…

3 weeks, 6 days ago

Short Long
View Episode
NBIS Has a $40B Backlog Wall Street Is Ignoring
NBIS Has a $40B Backlog Wall Street Is Ignoring

Nebius (NBIS) grew revenues 454% YoY — stock analysis & valuation: buy or sell?

👉 Want this level of research on ANY COMPANY IN THE WORLD... for FREE…

4 weeks ago

Short Long
View Episode
Why SNOW’s 37% Growth Can’t Justify Its 150x Multiple
Why SNOW’s 37% Growth Can’t Justify Its 150x Multiple

Snowflake hits 37% product growth — SNOW stock analysis, valuation & buy or sell

👉 Want this level of research on ANY COMPANY IN THE WORLD... for FRE…

1 month ago

Short Long
View Episode
UiPath: The 4.7x Sales AI Moat Wall Street Missed
UiPath: The 4.7x Sales AI Moat Wall Street Missed

UiPath (PATH) triggers 133% expected return — buy or sell? Valuation & stock analysis

👉 Want this level of research on ANY COMPANY IN THE WORLD... fo…

1 month ago

Short Long
View Episode
LULU at 10x PE is a Rare Asymmetric Recovery Play
LULU at 10x PE is a Rare Asymmetric Recovery Play

Lululemon (LULU) trades at 10.5x valuation — stock analysis: buy or sell?

👉 Want this level of research on ANY COMPANY IN THE WORLD... for FREE? Chec…

1 month ago

Short Long
View Episode
NTLA: The 12% Genetic Risk Threatening CRISPR's Cure
NTLA: The 12% Genetic Risk Threatening CRISPR's Cure

NTLA stock targets 1,502% potential upside — CRISPR valuation buy or sell analysis

👉 Want this level of research on ANY COMPANY IN THE WORLD... for F…

1 month ago

Short Long
View Episode
The Hidden Risk Behind Palo Alto's 109% Stock Rally
The Hidden Risk Behind Palo Alto's 109% Stock Rally

PANW stock analysis: 85x forward P/E tests safety limits — buy or sell breakdown

👉 Want this level of research on ANY COMPANY IN THE WORLD... for FRE…

1 month ago

Short Long
View Episode
Kraken PNG.V: The $7.5M Loss Masking 200% Sales Growth
Kraken PNG.V: The $7.5M Loss Masking 200% Sales Growth

Kraken Robotics (PNG.V) targets 200% revenue growth — stock analysis: buy or sell?

👉 Want this level of research on ANY COMPANY IN THE WORLD... for F…

1 month ago

Short Long
View Episode
SOFI Targets a 38% Margin That Wall Street Doubts
SOFI Targets a 38% Margin That Wall Street Doubts

SOFI stock analysis: 40% revenue growth signals escape velocity — buy or sell

👉 Want this level of research on ANY COMPANY IN THE WORLD... for FREE? …

1 month ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us